Maha Chowdhury is an accomplished scientist specializing in radiochemistry with a diverse background in analytical and quality control chemistry. Currently serving as Associate Scientist I at Ratio Therapeutics since July 2023, Maha leads innovative research initiatives and develops novel radiopharmaceutical compounds. Previously as a Chemist at Apotex Inc., significant achievements included developing and validating analytical methods while ensuring regulatory compliance. At AtomVie Global Radiopharma, roles included conducting quality control testing and authoring technical documentation. Maha's academic foundation includes an Honors Bachelors of Science in Biotechnology & Chemistry from the University of Toronto, where impactful research on vascular diseases was completed and presented at notable academic forums.
This person is not in any teams
This person is not in any offices